Serum ferritin, HO-1, and CD163 for the diagnosis of adult-onset Still's disease: a multicenter study

Serum ferritin, HO-1, and CD163 for the diagnosis of adult-onset Still's disease: a multicenter study - Serum ferritin, HO-1, and CD163 in adult-onset Still's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012912

Enrollment

400

Registered

2014-01-21

Start date

2014-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Definite and suspected adult-onset Still&#39

Interventions

Blood examination Blood examination

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult-onset Still's disease cases fulfilling Yamaguchi's criteria, and suspected cases, established cases for diagnosis of rheumatic diseases, infectious diseases, and malignancies, healthy controls.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Diagnosis of adult-onset Still's disease	—

Secondary

Measure	Time frame
Major and minor components in Yamaguchi's criteria, laboratory data, serum ferritin, HO-1, and serum CD163	—

Countries

Japan

Contacts

Public ContactYohei Kirino

Yokohama City University Graduate School of Medicine Department of Internal Medicine and Clinical Immunology

kirino@yokohama-cu.ac.jp045-787-2630

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Serum ferritin, HO-1, and CD163 for the diagnosis of adult-onset Still&#39;s disease: a multicenter study